DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Print   Email 

Ventiv Health, Inc. (VTIV) Named To Training Magazine Top 100 List


10/19/2005 5:13:12 PM

SOMERSET, N.J., April 4 /PRNewswire-FirstCall/ -- Ventiv Health, Inc. (Nausea: VTIV) announced today that Training Magazine, a professional development publication and advocate for workforce training as a business tool, has named Ventiv to its 2005 "Training Top 100" list. Ventiv was ranked #63 on this year's list of prestigious companies which extend across all industries; IBM (#1) Pfizer (#3), Lockheed Martin (#8), Wyeth (#12) and Roche Diagnostics (#21).

The 2005 Training Top 100 recognizes U.S. companies with the best internal training and employee performance. The magazine annually evaluates candidates on a series of qualitative and quantitative criteria, including strategic training goals; evaluative processes and mechanisms; metrics; workplace surveys; the ratio of dedicated training professionals to employees; amount of tuition reimbursement; training as a percentage of payroll; and number of hours dedicated to training.

"We are honored and pleased to be named as one of the top training companies," stated Peter Marchesini, Vice President, Training & Development, Ventiv Commercial Services. "This recognition is a true testament to the hard work and dedication of our training and development teams which continue to develop and expand the cutting edge programs we offer."

  Ventiv's broad training expertise and resource base includes:

  --  Client Training -- Ventiv trained over 4,000 sales professionals for
      its clients in 2004

  --  Continuous content enhancement -- Ventiv created and implemented an
      internal Representative Certification Program for all its training
      classes and began developing an OIG (Office of the Inspector
      General) standard training program module for its sales teams in
      2004.

  --  Professional Development Group -- provides a variety of customized
      client programs from selling skills, district manager training,
      communication skills, leadership and customer service

  --  Ventiv Academy -- offers various mentorship programs, leadership
      programs, and tuition reimbursement

  --  Pharmaceutical MBA Program, Rutgers University -- Brad Patten, Vice
      President, Marketing and Corporate Development, completes his third
      year teaching the Pharmaceutical Sales Management course within this
      graduate program.

To learn more about Training Magazine's "Top 100" list, visit http://www.trainingmag.com/ .

About Ventiv Health

Ventiv Health, Inc. is the leading provider of late-stage clinical, sales, marketing and compliance solutions to pharmaceutical and biotech companies. Ventiv is a multi-disciplinary company with a singular focus on providing excellence in customized solutions across the full spectrum of late-stage clinical, sales, marketing and compliance services, with both integrated and independent programs. Ventiv's approximately 4,000 employees support over 75 client organizations, including the world's Top 20 pharmaceuticals companies as well as emerging and specialty biotech leaders. For more information on Ventiv Health, visit http://www.ventiv.com/ .

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause Ventiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by Ventiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.

Ventiv Health, Inc.

CONTACT: Corporate: John Emery of Ventiv Health, Inc., CFO,+1-732-537-4804, investor@ventiv.com, Investors: Felicia Vonella of LazarPartners Ltd., +1-212-867-1762, fvonella@lazarpartners.com, Media: KellieWalsh of Lazar Partners Ltd., +1-646-871-8480, kwalsh@lazarpartners.com, allfor Ventiv Health, Inc.



Read at BioSpace.com

 Read Article at  Related Companies  News Categories
   


ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES